Treatment strategies for clozapine-induced hypotension: a systematic review

Treatment strategies for clozapine-induced hypotension: a systematic review

Background: Clozapine is the most effective medication for treatment–refractory schizophrenia but is associated with significant adverse drug effects, including hypotension and dizziness, which have a negative impact on quality of life and treatment compliance. Available evidence for the management...

Full description

Bibliographic Details
Main Authors:	Timothy David Tanzer, Thomas Brouard, Samuel Dal Pra, Nicola Warren, Michael Barras, Steve Kisely, Emily Brooks, Dan Siskind
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-05-01
Series:	Therapeutic Advances in Psychopharmacology
Online Access:	https://doi.org/10.1177/20451253221092931

Similar Items

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial
by: Karla Mayfield, et al.
Published: (2015-06-01)

Effects of semaglutide on body weight in clozapine-treated people with schizophrenia and obesity: study protocol for a placebo-controlled, randomised multicentre trial (COaST)
by: Dan Siskind, et al.
Published: (2023-07-01)

Meeting the mental health needs of low- and middle-income countries: the start of a long journey
by: Steve Kisely, et al.
Published: (2019-11-01)

Prevalence of frailty in severe mental illness: findings from the UK Biobank
by: Nicola Warren, et al.
Published: (2023-11-01)

Benefits following community treatment orders have an inverse relationship with rates of use: meta-analysis and meta-regression
by: Steve Kisely, et al.
Published: (2023-05-01)

Clozapine levels and therapeutic response: using individual patient meta-analysis data for a ROC Curve analysis
by: K. Northwood, et al.
Published: (2023-03-01)

A 40-year study of child maltreatment over the early life course predicting psychiatric morbidity, using linked birth cohort and administrative health data: protocol for the Childhood Adversity and Lifetime Morbidity (CALM) study
by: Steve Kisely, et al.
Published: (2023-03-01)

Clozapine-Encapsulated Binary Mixed Micelles in Thermosensitive Sol–Gels for Intranasal Administration
by: Madeleine S. A. Tan, et al.
Published: (2022-01-01)

Clozapine associated pulmonary embolism: systematic review
by: Rakshya Poudyal, et al.
Published: (2019-07-01)

Augmentation strategies for treatment-refractory clozapine patients
by: O. Freudenreich
Published: (2021-04-01)

Dry mouth effects from drugs used for depression, anxiety, schizophrenia and bipolar mood disorder in adults: systematic review
by: Cherilyn Xue Wei Teoh, et al.
Published: (2023-03-01)

Mandatory certification for clozapine prescribing
by: Dan Cohen, et al.
Published: (2021-01-01)

Clozapine cessation
by: H. Ktari, et al.
Published: (2022-06-01)

Clozapine in the elderly: Concerns and challengesClozapine in the elderly: Concerns and challenges
by: Sandeep Grover
Published: (2023-01-01)

Biological predictors of clozapine response: a systematic review
by: Samanaite, R, et al.
Published: (2018)

Clozapine combination and augmentation strategies in patients with schizophrenia - recommendations from an international expert survey among the treatment response and resistance in psychosis (TRRIP) working group
by: Wagner, Elias, et al.
Published: (2021)

The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review
by: Thomas Van der Poorten, et al.
Published: (2019-11-01)

Clozapine and urinary incontinence
by: A. Osca Oliver, et al.
Published: (2022-06-01)

Repurposing clozapine in psychosis
by: Oloyede, E
Published: (2024)

Clozapine-induced hypertension
by: Vrushti Bharat Patil, et al.
Published: (2022-01-01)

A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
by: Tiffanie Sze Wing Pang, et al.
Published: (2023-09-01)

Quarantine: use with care
by: Steve Kisely
Published: (2021-09-01)

The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
by: Ebenezer Oloyede, et al.
Published: (2023-06-01)

Emergency department presentations for deliberate self-harm and suicidal ideation in 25–39 year olds following agency-notified child maltreatment: results from the Childhood Adversity and Lifetime Morbidity (CALM) study
by: S. Kisely, et al.
Published: (2024-01-01)

Emergency department presentations for deliberate self-harm and suicidal ideation in 25–39 year olds following agency-notified child maltreatment: results from the Childhood Adversity and Lifetime Morbidity (CALM) study – CORRIGENDUM
by: S. Kisely, et al.
Published: (2024-01-01)

Clozapine-Induced Myocarditis and Pericarditis
by: Othman, Zahiruddin, et al.
Published: (2014)

Practitioner attitudes to clozapine initiation.
by: Gee, S, et al.
Published: (2013)

Practitioner attitudes to clozapine initiation
by: Gee, S, et al.
Published: (2014)

Monitoring sertraline and clozapine levels
by: A. Rodriguez Campos, et al.
Published: (2022-06-01)

Dealing With Clozapine-Induced Sialorrhea
by: J. Sá Couto, et al.
Published: (2022-06-01)

Ethnic inequalities in treatment with clozapine
by: D. Fonseca De Freitas, et al.
Published: (2022-06-01)

The Effect of Clozapine on Tremor in Patients with Parkinson’s Disease who were Initiated Clozapine For Psychotic Symptoms
by: Emel Oğuz Akarsu, et al.
Published: (2013-12-01)

The burden of perioperative hypertension/hypotension: A systematic review
by: Irene Lizano-Díez, et al.
Published: (2022-01-01)

Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review
by: Maria Skokou, et al.
Published: (2022-07-01)

Leukocytosis Associated with Clozapine Treatment: A Case Series and Systematic Review of the Literature
by: Pasquale Paribello, et al.
Published: (2021-08-01)

Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
by: Jessica W. Y. Yuen, et al.
Published: (2018-04-01)

Clozapine responsive catatonia: A series of five cases
by: Somsubhra Chattopadhyay, et al.
Published: (2012-01-01)

Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
by: Yuki Kikuchi, et al.
Published: (2023-11-01)

Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia
by: Jessica Foster, et al.
Published: (2017-01-01)

Discussing clozapine adverse effects and monitoring strategies: a focus on ethnic diversity
by: Ana Teresa Caliman-Fontes, et al.
Published: (2023-11-01)